Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Terra Tech Corp. TRTC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
18/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Terra Tech Corp. (TRTC) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.27. It has a SharesGrow Score of 17/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $14M, -17.9%/yr average growth. Net income is $30M (loss), growing at -1.3%/yr. Net profit margin is -210.8% (negative). Gross margin is 25.2% (-5.3 pp trend).

Balance sheet: total debt is $15M against $55M equity (Debt-to-Equity (D/E) ratio 0.27, conservative). Current ratio is 1.42 (adequate). Debt-to-assets is 14.6%. Total assets: $100M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 50/100 (Partial), Moat 14/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

TRTC SharesGrow Score Overview

22/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 14/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TRTC

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
TRTC: -17.9%/yr revenue is, -1.3%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
50/100
Balance sheet TRTC: Debt-to-Equity (D/E) ratio 0.27 (conservative), Current ratio is 1.42 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
14/100
TRTC: Gross margin is 25.2% (-5.3 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 14/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
TRTC: Net profit margin is -210.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.2656-0.294
Volume678.46K
Avg Volume (30D)1.11M
Beta (1Y)2.28
Share Statistics
EPS (TTM)-0.28
Shares Outstanding$106.04M
IPO Date2012-04-23
Employees50
CEODerek A. Peterson
Financial Highlights & Ratios
Revenue (TTM)$14.29M
Gross Profit$3.6M
EBITDA$-20.01M
Net Income$-30.12M
Operating Income$-21M
Total Cash$34.93M
Total Debt$14.67M
Net Debt$13.78M
Total Assets$100.29M
Price / Earnings (P/E)-1
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD

Price Chart

Track all markets on TradingView
TRTC
Terra Tech Corp. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.27 52WK RANGE 0.29

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message